Zivo BioScience, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 50
Rang # Quantité totale PI 27 780
Note d'activité PI 2,4/5.0    35
Rang # Activité PI 21 807
Symbole boursier ZIVO (nasdaq)
ISIN US98978N2009
Capitalisation 69.00M  (USD)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

21 4
11 1
13 0
0
 
Dernier brevet 2025 - Use of variovorax microbes as an...
Premier brevet 2006 - Composition and use of phyto-per...
Dernière marque 2024 - Z ZIVOLIFE
Première marque 2018 - KALGAE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Use of variovorax microbes as an alternative treatment for coccidiosis. Compounds capable of sel...
Invention Algoriphagus sp, bosea sp, brevundimonas sp, desulfovibrio sp, microbacterium sp, sphingomonas sp...
P/S Powdered nutritional supplement drink mix containing microalgae
Invention Immune priming to accelerate/enhance immune response through administration of natural immune mod...
2023 Invention Use of tlr4 modulator in the treatment of coccidiosis. An effective treatment mechanism in contr...
P/S Non-medicated topical preparations derived from algae, namely, creams, serums, and masques for im...
2022 Invention Brevundimonas sp for use in disease prevention and treatment. An improved agent and treatment me...
Invention Brevundimonas sp for use in disease prevention and treatment. An improved agent and treatment met...
Invention Brevundimonas sp for use in disease prevention and treatment. BrevundimonasBrevundimonas. Consump...
P/S Animal feed supplements; dietary and nutritional supplements; dietary and nutritional supplements...
Invention Maturation of immune and metabolic processes via algal biomass and/or related material administer...
2021 Invention Agents and method for improviing gut health. An improved agent and treatment method for a broad ...
Invention Natural feed composition derived from fresh water algal cultures for the promotion of animal grow...
Invention The use of variovorax microbes as an alternative treatment for coccidiosis. Compounds capable of ...
Invention Enhancement of vaccine efficacy via biomass and/or related material in animal drink and feed. An...
Invention Positive latency effects on coccidiosis prevention and treatment via animal feed. An effective t...
Invention Positive latency effects on coccidiosis prevention and treatment via animal feed. An effective tr...
Invention Use of tlr4 modulator in the treatment of coccidiosis. An effective treatment mechanism in contro...
Invention Use of tlr4 modulator in the treatment of coccidiosis. VariovoraxRhodobacterVariovorax paradoxusR...
2019 Invention Algal feed ingredient for controlling the effects of coccidiosis and necrotic enteritis in poultr...
Invention Compounds and methods for affecting cytokines. The present invention discloses isolates and fract...
2018 P/S Processed algae for human consumption; Dried edible algae.
Invention Dietary supplements, food ingredients and foods comprising high-protein algal biomass. An algal-...
Invention Dietary supplements, food ingredients and foods comprising high-protein algal biomass. An algal-d...
2017 Invention Nutritional support for animals via administration of an algal derived supplement. An algal bioma...
2016 Invention Agents and mechanisms for treating hypercholesterolemia. A method of treating hypercholesterolemi...
Invention Methods of modulating immune and inflammatory responses via administration of an algal biomass. A...
2014 Invention Composition and method for affecting cytokines and nf-κb. The present invention discloses a compo...
2010 Invention Use of an extract derived from atcc #pta-5863 as an anti-inflammatory and anti-viral agent.
Invention Composition and use of phyto-percolate for treatment of disease. This invention relates generally...